201 related articles for article (PubMed ID: 38187574)
1. Spatial transcriptomics analysis identifies a unique tumor-promoting function of the meningeal stroma in melanoma leptomeningeal disease.
Alhaddad H; Ospina OE; Khaled ML; Ren Y; Forsyth P; Pina Y; Macaulay R; Law V; Tsai KY; Cress WD; Fridley B; Smalley I
bioRxiv; 2023 Dec; ():. PubMed ID: 38187574
[TBL] [Abstract][Full Text] [Related]
2. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
[TBL] [Abstract][Full Text] [Related]
3. A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma.
Law V; Chen Z; Vena F; Smalley I; Macaulay R; Evernden BR; Tran N; Pina Y; Puskas J; Caceres G; Bayle S; Johnson J; Liu JKC; Etame A; Vogelbaum M; Rodriguez P; Duckett D; Czerniecki B; Chen A; Smalley KSM; Forsyth PA
Neuro Oncol; 2022 Oct; 24(10):1673-1686. PubMed ID: 35213727
[TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases.
Khaled ML; Tarhini AA; Forsyth PA; Smalley I; Piña Y
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980770
[TBL] [Abstract][Full Text] [Related]
6. CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease.
Najem H; Marisetty A; Horbinski C; Long J; Huse JT; Glitza Oliva IC; Ferguson SD; Kumthekar PU; Wainwright DA; Chen P; Lesniak MS; Burks JK; Heimberger AB
Front Immunol; 2021; 12():745893. PubMed ID: 34691054
[TBL] [Abstract][Full Text] [Related]
7. Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases.
Lowe SR; Wang CP; Brisco A; Whiting J; Arrington J; Ahmed K; Yu M; Robinson T; Oliver D; Etame A; Tran N; Beer Furlan A; Sahebjam S; Mokhtari S; Piña Y; Macaulay R; Forsyth P; Vogelbaum MA; Liu JKC
Neuro Oncol; 2022 Aug; 24(8):1307-1317. PubMed ID: 35092434
[TBL] [Abstract][Full Text] [Related]
8. Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.
Chorti E; Kebir S; Ahmed MS; Keyvani K; Umutlu L; Kanaki T; Zaremba A; Reinboldt-Jockenhoefer F; Knispel S; Gratsias E; Roesch A; Ugurel S; Scheffler B; Schadendorf D; Livingstone E; Meier F; Glas M; Zimmer L
Eur J Cancer; 2021 May; 148():395-404. PubMed ID: 33789203
[TBL] [Abstract][Full Text] [Related]
9. Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease.
Khaled ML; Ren Y; Kundalia R; Alhaddad H; Chen Z; Wallace GC; Evernden B; Ospina OE; Hall M; Liu M; Darville LNF; Izumi V; Chen YA; Pilon-Thomas S; Stewart PA; Koomen JM; Corallo SA; Jain MD; Robinson TJ; Locke FL; Forsyth PA; Smalley I
bioRxiv; 2023 Dec; ():. PubMed ID: 38187773
[TBL] [Abstract][Full Text] [Related]
10. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.
Piña Y; Yadugiri S; Yeboa DN; Ferguson SD; Forsyth PA; Oliva ICG
Curr Oncol Rep; 2022 Jan; 24(1):43-54. PubMed ID: 35059999
[TBL] [Abstract][Full Text] [Related]
11. Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases.
Li Y; Pan W; Connolly ID; Reddy S; Nagpal S; Quake S; Gephart MH
J Neurooncol; 2016 May; 128(1):93-100. PubMed ID: 26961773
[TBL] [Abstract][Full Text] [Related]
12. Leptomeningeal dissemination in pediatric brain tumors.
Cocito C; Martin B; Giantini-Larsen AM; Valcarce-Aspegren M; Souweidane MM; Szalontay L; Dahmane N; Greenfield JP
Neoplasia; 2023 May; 39():100898. PubMed ID: 37011459
[TBL] [Abstract][Full Text] [Related]
13. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).
Ferguson SD; Bindal S; Bassett RL; Haydu LE; McCutcheon IE; Heimberger AB; Li J; O'Brien BJ; Guha-Thakurta N; Tetzlaff MT; Tawbi H; Davies MA; Glitza IC
J Neurooncol; 2019 May; 142(3):499-509. PubMed ID: 30847840
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance.
Smalley I; Law V; Wyatt C; Evernden B; Fang B; Koomen JM; Welsh EA; Macaulay RJB; Forsyth PA; Smalley KSM
Clin Cancer Res; 2020 May; 26(9):2163-2175. PubMed ID: 31924735
[TBL] [Abstract][Full Text] [Related]
15. Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.
Smalley KS; Fedorenko IV; Kenchappa RS; Sahebjam S; Forsyth PA
Int J Cancer; 2016 Sep; 139(6):1195-201. PubMed ID: 27084046
[TBL] [Abstract][Full Text] [Related]
16. Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid.
White MD; Klein RH; Shaw B; Kim A; Subramanian M; Mora JL; Giobbie-Hurder A; Nagabhushan D; Jain A; Singh M; Kuter BM; Nayyar N; Bertalan MS; Stocking JH; Markson SC; Lastrapes M; Alvarez-Breckenridge C; Cahill DP; Gydush G; Rhoades J; Rotem D; Adalsteinsson VA; Mahar M; Kaplan A; Oh K; Sullivan RJ; Gerstner E; Carter SL; Brastianos PK
JAMA Netw Open; 2021 Aug; 4(8):e2120040. PubMed ID: 34369989
[TBL] [Abstract][Full Text] [Related]
17. A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease.
Law V; Baldwin M; Ramamoorthi G; Kodumudi K; Tran N; Smalley I; Duckett D; Kalinski P; Czerniecki B; Smalley KSM; Forsyth PA
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33586709
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal dissemination: a sinister pattern of medulloblastoma growth.
Fults DW; Taylor MD; Garzia L
J Neurosurg Pediatr; 2019 Feb; 23(5):613-621. PubMed ID: 30771762
[TBL] [Abstract][Full Text] [Related]
20. Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal Metastases.
Smalley I; Chen Z; Phadke M; Li J; Yu X; Wyatt C; Evernden B; Messina JL; Sarnaik A; Sondak VK; Zhang C; Law V; Tran N; Etame A; Macaulay RJB; Eroglu Z; Forsyth PA; Rodriguez PC; Chen YA; Smalley KSM
Clin Cancer Res; 2021 Jul; 27(14):4109-4125. PubMed ID: 34035069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
